• Science & Technology
• Health & Medicine

How we can reduce cancer risk in inflammatory bowel disease patients by blocking a Hedgehog

If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that.  If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that. 

23 August 2022

• Science & Technology
• Health & Medicine

How erectile dysfunction drugs could be the key to overcoming treatment resistance in oesophageal cancer

Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect.  Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect. 

21 June 2022

• Science & Technology

Picking out the patterns: How scientists are finding cancer’s signatures in tumour DNA

An international team of researchers have identified 21 common faults in cancer DNA using an algorithm that works similarly to Netflix An international team of researchers have identified 21 common faults in cancer DNA using an algorithm that works similarly to Netflix

15 June 2022

• Science & Technology

The path to least resistance: How our researchers are outsmarting cancer’s survival skills

Our scientists across the country are working hard to tackle drug resistance – one of cancer's cruellest curveballs. Our scientists across the country are working hard to tackle drug resistance – one of cancer's cruellest curveballs.

25 May 2022

• Science & Technology

How we are working with industry to translate research into real benefits for patients 

You may not know that as well as funding cancer research, we also work with industry and academia to develop promising ideas and turn them into real benefit for patients. Find out about Cancer Research Horizons. You may not know that as well as funding cancer research, we also work with industry and academia to develop promising ideas and turn them into real benefit for patients. Find out about Cancer Research Horizons.

26 April 2022

• Science & Technology

A urine test for bladder cancer: What’s the latest?

Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in. Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in.

16 April 2022

• Science & Technology

Detecting multiple cancers with a ‘simple' blood test: Where are we?

A blood test capable of catching any cancer at an early stage before any symptoms may sound like science fiction but just how close are researchers to making it a reality? A blood test capable of catching any cancer at an early stage before any symptoms may sound like science fiction but just how close are researchers to making it a reality?

14 April 2022

• Science & Technology

Personalised blood test could help predict which lung cancers might return

Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test. Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.

1 April 2022

• Science & Technology

Piecing together the puzzle: Antibiotics, the microbiome and bowel cancer

Our researchers across the world are investigating a potential link between bowel cancer and the microbiome, and the potential role antibiotics might play. Our researchers across the world are investigating a potential link between bowel cancer and the microbiome, and the potential role antibiotics might play.

15 March 2022